ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

アゴメラチン

Agomelatine

HCID 82148
反応を作成
印刷

データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます

基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
138112-76-2
標準SMILES
COc1ccc2cccc(CCNC(C)=O)c2c1
InChIKey
YJYPHIXNFHFHND-UHFFFAOYSA-N
分子式
C15H17NO2
平均分子量
243.3 g/mol
単同位体質量
243.12592879

概要

Agomelatine is a member of acetamides.

名称と識別子

優先名称
Agomelatine
IUPAC
N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide
現地名
アゴメラチン
英語名
Agomelatine
分子式
C15H17NO2
分子量
243.3

名称と別名

Agomelatine138112-76-2ThymanaxValdoxanS20098S-20098AgomelatinaAGO-178S 20098N-(2-(7-methoxy-1-naphthyl)ethyl)acetamideagomelatinumAGO178
名称をさらに表示
アゴメラチンN-[2-(7-メトキシ-1-ナフタレニル)エチル]アセトアミドN-[2-(7-メトキシナフタレン-1-イル)エチル]アセトアミドN-[2-(7-メトキシ-1-ナフチル)エチル]アセトアミドAGOMELATINGOMELATINEMELITORAgomelatine original crystal formomeLatineAgomeLMelitorCS-1963
DTXSID3057642137R1N49ADN-[2-(7-methoxy-1-naphthyl)ethyl]acetamideDTXCID4031431RefChem:110192N06AX22N-(2-(7-Methoxynaphthalen-1-yl)ethyl)acetamideN-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide

データベース識別子

CAS
138112-76-2
PubChem CID
82148
DTXSID
DTXSID3057642
ChEMBL
CHEMBL10878
ChEBI
CHEBI:134990
UNII
137R1N49AD
EC Number
629-727-7
Nikkaji
J481.046E

物性

構造計算による物性補完中

XLogP
2.7
極性表面積
38.3 Ų
水素結合供与体数
1
水素結合受容体数
2
回転可能結合数
4
重原子数
18
形式電荷
0
複雑度
280

実験および物理化学的性質

Drugs · 3 件

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals

Pharmaceuticals -> Antidepressants

Solubility · 2 件

~0.5 mg/ml in 1:1 EtOH:PBS (pH 7.2); ~30 mg/ml in EtOH, DMF & DMSO

7.76e-03 g/L

Human Drugs · 2 件

Breast Feeding; Lactation; Milk, Human; Antidepressants

EMA approved medicines: Human medicine

Physical DescriptionSolid
Collision Cross Section156.3 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

物理化学的性質

融点
107 · 107-109°C
沸点
478.8 · 478.8±28.0 °C(Predicted)
比重(密度)
1.109 · 1.109±0.06 g/cm3(Predicted)
貯蔵温度
2 · 2-8°C
溶解性
50 mg/mL · DMSO:>50mg/mL
外見
粉
酸解離定数(Pka)
16.17 · 16.17±0.46(Predicted)

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 5 件

This chemical does not meet GHS hazard criteria for 1.9% (1 of 54) of reports.

Warning

H315 (22.2%): Causes skin irritation [Warning Skin corrosion/irritation]

P261, P264, P264+P265, P271, P273, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P391, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 54 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Hazard Classes and CategoriesSkin Irrit. 2 (22.2%)

毒性情報

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

安全データ

wgk
3
rtecs
AC5956323
ridadr
UN 3077 9 / PGIII
毒性
mouse,LD50,oral,> 1gm/kg (1000mg/kg),United States Patent Document. Vol. #5318994,
hs_code
29241990
risk_code
50
hazard_code
N
safety_code
61
Hazard Classifications
Aquatic Acute 1Aquatic Chronic 1
ストレージクラス
11 - Combustible Solids

化学と産業

薬理情報

ATC Code · 3 件

N06AX22

N - Nervous system

QN - Nervous system

Protein Binding> 95%
Pharmacodynamics · 1 件

Agomelatine resynchronises circadian rhythms in animal models of delayed sleep phase syndrome and other circadian rhythm disruptions. It increases noradrenaline and dopamine release specifically in the frontal cortex and has no influence on the extracellular levels of serotonin. Agomelatine has shown an antidepressant-like effect in animal depression models, (learned helplessness test, despair test, and chronic mild stress) circadian rhythm desynchronisation, and in stress and anxiety models. In humans, agomelatine has positive phase shifting properties; it induces a phase advance of sleep, body temperature decline and melatonin onset. Controlled studies in humans have shown that agomelatine is as effective as the SSRI antidepressants paroxetine and sertraline in the treatment of major depression

Mechanism of ActionThe novel antidepressant agent, agomelatine, behaves as an agonist at melatonin receptors (MT1 and MT2) and as an antagonist at serotonin (5-HT)(2C) receptors.
Biological Half-Life<2 hours
Metabolism/MetabolitesHepatic (90% CYP1A2 and 10% CYP2C9).
MeSH Pharmacological ClassificationDrugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety.
Absorption, Distribution and ExcretionBioavailability is less than 5%.
Cellular LocationsMembrane

用途と製造

関連反応

35 件
反応記録を作成
HRID 112654 の反応式
HRID 112654生成物として
HRID 117375 の反応式
HRID 117375反応物として
HRID 123320 の反応式
HRID 123320生成物として
HRID 232780 の反応式
HRID 232780反応物として
HRID 243636 の反応式
HRID 243636生成物として
HRID 243637 の反応式
HRID 243637生成物として
HRID 243638 の反応式
HRID 243638生成物として
HRID 351136 の反応式
HRID 351136反応物として
前へ1 / 5 ページ

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
色
ホワイトからオフホワイト
Merck
14 · 14,190
InChI
InChI=1S/C15H17NO2/c1-11(17)16-9-8-13-5-3-4-12-6-7-14(18-2)10-15(12)13/h3-7,10H,8-9H2,1-2H3,(H,16,17)
InChIKey
YJYPHIXNFHFHND-UHFFFAOYSA-N
SMILES
C(NCCC1=C2C(C=CC(OC)=C2)=CC=C1)(=O)C
CAS データベース
138112 · 138112-76-2(CAS DataBase Reference)

化学的性質

化学的特性White Solid

UsesUse (kg; approx.) in Germany (2009): >100
応用分野 · 2 件

説明Agomelatine is an agonist of melatonin (MT) receptors and a derivative of melatonin . It binds to MT1 and MT2 receptors (Kis = 0.14 and 0.41 nM, respectively) and has an EC50 value of 0.1 nM in a [35S]GTPγS binding assay using CHO cells expressing MT2 receptors. Agomelatine is also an antagonist of the serotonin (5-HT) receptor subtypes 5-HT2B and 5-HT2C (Kis = 0.26 and 0.71 nM, respectively, for the human receptors). Agomelatine (40 mg/kg) inhibits the penile erection response induced by the 5-HT2 agonist Ro 60-0175 in rats. It also increases extracellular levels of noradrenaline and dopamine in the frontal cortex of freely moving rats when administered at doses ranging from 20 to 80 mg/kg. Agomelatine (10 mg/kg) reduces immobility time in the forced swim test and increases the amount of time spent in the open arms of the elevated plus maze in mice, indicating antidepressant-like and anxiolytic-like activity, in a transgenic neuroendocrine model of depression. It also increases the rate of readjustment to circadian activity cycles following an induced phase shift.

使用Agomelatine is a melatoninergic agonist and selective antagonist of 5-HT2C receptors, and has been shown to be active in several animal models of depression. Agomelatine (S20098) displayed pKi values of 6.4 and 6.2 at native (porcine) and cloned, human (h)5-hydroxytryptamine (5-HT)2C receptors, respectively.

上流・下流製品情報

上流原料

1384536-35-9185336-04-32-(7-Methoxy-1-naphthyl)ethylamine hydrochloride7-メトキシ-1-ナフチルアセトニトリルAgomelatine Impurity 12-(7-メトキシ-1-ナフチル)エタンアミン2-(7-Methoxynaphthalen-1-yl)acetamide

下流製品

N-acetyl-N-(2-(7-Methoxynaphthalen-1-yl)ethyl)acetaMide